newsfilter
← Latest News
GlobeNewswire·

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

  • Veracyte, Inc. (NASDAQ: VCYT) will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference.
  • The presentation is scheduled for Tuesday, September 15, 2026, at 7:00 a.m. Eastern Time.
  • A live audio webcast will be available on Veracyte's investor website, with a replay accessible for 90 days post-broadcast.
  • The company utilizes a Diagnostics Platform combining genomic data, bioinformatics, AI, & an evidence-generation engine for cancer care innovation.
  • Veracyte's product portfolio includes the Afirma® Genomic Sequencing Classifier, Decipher® Bladder Genomic Classifier, Decipher® Prostate Genomic Classifier, Prosigna® Breast Risk of Recurrence, & the TrueMRD™ Monitoring Test for MIBC.
  • Investor inquiries should be directed to Kelly Gura, while media inquiries should be directed to Molly Cornbleet.